Company: GEHC
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001932393-25-000005
Chunk: 176

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 7
Chunk 176
---
 526660Total revenues    $19,672$19,552$18,3411%7%1%8%

(1) Financial information not presented within the reportable segments, shown within the Other category, represents HealthCare Financial Services which does not meet the definition of an operating segment.

Revenues by RegionFor the years ended December 312024202320222024 vs. 2023 % change2023 vs. 2022 % changeUnited States and Canada (“USCAN”)    $8,981$8,551$8,1305%5%Europe, the Middle East, and Africa (“EMEA”)    5,0515,0584,684—%8%China region    2,3602,7852,531(15)%10%Rest of World    3,2803,1582,9964%5%Total revenues    $19,672$19,552$18,3411%7%

____________________

*Non-GAAP Financial Measure

41

For the year ended December 31, 2024

Total revenues were $19,672 million, growing 1% or $120 million. The reported growth was largely due to Sales of services increasing 3% or $172 million primarily driven by increased pricing.

The segment revenues were as follows:

•Imaging segment revenues were $8,855 million, decreasing 1% or $89 million, following high single-digit revenue growth in the prior year, with current year impacts from lower sales volume in China and unfavorable foreign currency impacts;

•AVS segment revenues were $5,131 million, growing 1% or $37 million with an increase in sales volume in USCAN partially offset by lower sales volume in China and unfavorable foreign currency impacts;

•PCS segment revenues were $3,125 million, decreasing 1% or $17 million primarily due to decreased volume in the Monitoring Solutions product line following growth in the prior year and unfavorable foreign currency impacts, partially offset by increased volume in the Maternal Infant Care product line; and

•PDx segment revenues were $2,508 million, growing 9% or $202 million with growth in the USCAN and EMEA regions driven by growth in volume, an increase in price, and new product introductions.

The regional revenues were as follows:

•USCAN revenues were $8,981 million, growing 5% or $430 million with growth across all segment revenues;

•EMEA revenues were